News
10-28-2011, 02:22 AM
DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.
More... (http://www.news-medical.net/news/20111028/DiaGenic-reports-operating-revenue-of-NOK-276-thousand-for-third-quarter-2011.aspx)
More... (http://www.news-medical.net/news/20111028/DiaGenic-reports-operating-revenue-of-NOK-276-thousand-for-third-quarter-2011.aspx)